Acalabrutinib
- ₹0
- Product name: Acalabrutinib
- CAS: 1420477-60-6
- MF: C26H23N7O2
- MW: 465.51
- EINECS:814-272-0
- MDL Number:MFCD29472294
- Synonyms:acalabrutinib;Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-;ACP196,Acalabrutinib;4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide;(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide;Acalabrutinib (ACP-196);EOS-60753;ACP-196; ACP196; ACP 196
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Melting point :>133°C (dec.)
Density :1.37±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Soluble in DMSO (up to at least 25 mg/ml)
pka :11.47±0.70(Predicted)
form :solid
color :Yellow
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChIKey :WDENQIQQYWYTPO-IBGZPJMESA-N
SMILES :C(NC1=NC=CC=C1)(=O)C1=CC=C(C2=C3N(C([C@@H]4CCCN4C(=O)C#CC)=N2)C=CN=C3N)C=C1
Density :1.37±0.1 g/cm3(Predicted)
storage temp. :Refrigerator
solubility :Soluble in DMSO (up to at least 25 mg/ml)
pka :11.47±0.70(Predicted)
form :solid
color :Yellow
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
InChIKey :WDENQIQQYWYTPO-IBGZPJMESA-N
SMILES :C(NC1=NC=CC=C1)(=O)C1=CC=C(C2=C3N(C([C@@H]4CCCN4C(=O)C#CC)=N2)C=CN=C3N)C=C1
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Acalabrutinib (ACP-196) is a selective second-generation Bruton's tyrosine kinase (BTK) inhibitor with an IC50 of 3 nM, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. ACP-196 has improved target specificity over ibrutinib with 323-, 94-, 19- and 9-fold selectivity over the other TEC kinase family members (ITK, TXK, BMX, and TEC, respectively) and no activity against EGFR.More related product prices
Valsartan Levetiracetam Testosterone-undecanoate Pregabalin 5-Azacytidine Volasertib (BI 6727) RESINIFERATOXINRelated product price
- Valsartan
₹3600-43527.33 - Levetiracetam
₹7400-31046.1 - Pregabalin
₹8053.8-52815.18
Suppliers and manufacturers
AVD pharmaceuticals Pvt Ltd
Salvavidas Pharmaceutical Pvt., Ltd.
Vijaya Pharma And Life Science
Svak Life Sciences
SynZeal Research Pvt Ltd
Pharma Affiliates
CLEARSYNTH LABS LTD.
Pharmaffiliates Analytics and Synthetics P. Ltd
Triveni Interchem Private Limited (Group Of Triveni...
Clearsynth Labs Research Centre